Stay updated with breaking news from Interstitial Lung Disease Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
· Established market leader in stroke AI imaging receives its first FDA clearance in the lung imaging space.· With this expanded foundation of AI-driven healthcare solutions, the Oxford-based company remains committed t...
Panel discussion will highlight LTI-03, Aileron’s novel Caveolin-1-related peptide, for the treatment of idiopathic pulmonary fibrosis...
Rahaghi Brings Over 25 Years of Clinical Care and Leadership to Growing FoundationCHICAGO , Sept. 5, 2023 /PRNewswire/ -- The Pulmonary Fibrosis F...
WELLNESS ON WHEELS: Local venues will host the Warren City Health District’s “Wellness on Wheels” Mobile Health Unit. The vehicle has visited each ward in
A new drug has shown promise in Phase II trials, slowing down the progression of interstitial lung disease in rheumatoid arthritis sufferers.